Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
drugs
2
×
fda
life sciences
national blog main
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
akcea therapeutics
alder biopharmaceutical
allergan
alnylam pharmaceuticals
american academy of neurology
amgen
atogepant
barry greene
biohaven
bob azelby
boston
boston university
botox
boulder/denver blog main
boulder/denver top stories
brian abrahams
calcitonin gene-related peptide
dan ollendorf
detroit blog main
detroit top stories
eli lilly
eptinezumab
erenumab
fremanezumab
galcanezumab
What
decades
2
×
fda
2
×
ago
alnylam
approval
approve
arguments
awaits
big
biological
class
commercialized
companies
competitors
crossed
decision
discovered
drug
drugs
fingers
friday
historic
make
medicine
meeting
migraine
neuro
new
oral
patients
potential
rna
therapies
time
trick
uses
won
year
Language
Current search:
drugs
×
fda
×
decades
×
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
